Advertisement
News
Advertisement

Reportlinker Adds Autistic Disorder - Pipeline Assessment and Market Forecasts to 2017

Tue, 09/14/2010 - 11:34am
Bio-Medicine.Org

NEW YORK, Sept. 14 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Autistic Disorder - Pipeline Assessment and Market Forecasts to 2017

http://www.reportlinker.com/p0293174/Autistic-Disorder---Pipeline-Assessment-and-Market-Forecasts-to-2017.html

Autistic Disorder - Pipeline Assessment and Market Forecasts to 2017

SummaryGlobalData, the industry analysis specialist, has released its new report, "Autistic Disorder – Pipeline Assessment and Market Forecasts to 2017". The report is an essential source of information and analysis on the global Autistic Disorder market. The report identifies the key trends shaping and driving the global Autistic Disorder market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Autistic Disorder sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

GlobalData has estimated the global autistic disorder therapeutics market to be valued at $331m in 2009. It is expected to grow to $765m with a compound annual growth rate (CAGR) of 11.05% by 2017. This growth is primarily attributed to the high increase in prevalence and also the rapid increase in public awareness about the disease. The existing market is weak due to a lack of diagnostic techniques, and the poor saf

'/>"/>

SOURCE

Topics

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading